RIC Stool Softener Recalled Due to Storage Temperature Deviations
RIC Stool Softener Softgels (SKUs 917000 and 902493) distributed to Family Dollar Stores nationwide from April 30, 2022 through June 10, 2022 are recalled due to improper storage temperature conditions.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall for CGMP manufacturing deviations (improper storage temperature). The recall is precautionary in nature, addressing a manufacturing process issue without reported illnesses or injuries.
Plain-English summary
RIC Stool Softener Softgels (100 count) are being recalled due to storage temperature deviations during manufacturing. Two product SKUs (917000 and 902493) distributed by Family Dollar Stores, LLC to Family Dollar Stores locations nationwide from April 30, 2022 through June 10, 2022 are affected.
The products were held outside appropriate storage temperature conditions in violation of Current Good Manufacturing Practice (CGMP) standards.
Consumers should stop using the affected products and dispose of them safely. Those with questions should contact the recalling firm.
The recalled product
- Product
- RIC STOOL SOFTENER SOFTGEL 100 CT SKU 917000 RIC STOOL SOFTNER 100 CT SKU 902493 distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.
- Manufacturer
- Family Dollar Stores, Llc.
- Category
- Drug
- Hazard
- improper-storage
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- SKUs: 917000
- 902493
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27